A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema

NCT07783425 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
1375
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer